Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
Self-renewal and pluripotency in human embryonic stem cells (hESCs) depends upon the function of a remarkably small number of master transcription factors (TFs) that include OCT4, SOX2, and NANOG. Endogenous factors that regulate and maintain the expression of master TFs in hESCs remain largely unknown and/or uncharacterized. Here, we use a genome-wide, proteomics approach to identify proteins associated with the OCT4 enhancer. We identify known OCT4 regulators, plus a subset of potential regulators including a zinc finger protein, ZNF207, that plays diverse roles during development. In hESCs, ZNF207 partners with master pluripotency TFs to govern self-renewal and pluripotency while simultaneously controlling commitment of cells towards ectoderm through direct regulation of neuronal TFs, including OTX2. The distinct roles of ZNF207 during differentiation occur via isoform switching. Thus, a distinct isoform of ZNF207 functions in hESCs at the nexus that balances pluripotency and differentiation to ectoderm.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6197280 | PMC |
| http://dx.doi.org/10.1038/s41467-018-06908-5 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Targeting stem cells with oncolytic viruses: a mathematical modelling approach.
Math Biosci Eng
July 2025
Department of Mathematics and Statistics, University of New Brunswick, Fredericton, NB, Canada.
Intratumoural epigenetic heterogeneity, which affects the outcome of many cancer treatments, results from stem cell-differentiated cell hierarchy. Cancer stem cells, also known as tumour-initiating cells, are a pluripotent subpopulation of tumour cells capable of creating a tumour clone through self-renewal and differentiation. Oncolytic viral therapy is a category of cancer therapeutics with high specificity in targeting cancer cells while leaving normal cells unharmed.
View Article and Find Full Text PDFBACH1 recruits STAT3 to enhance leukemia inhibitory factor receptor activity and augments the self-renewal capacity of mouse embryonic stem cells.
Stem Cell Res Ther
September 2025
Department of Physiology and Pathophysiology, School of Basic Medical Sciences, Department of Rheumatology, Zhongshan Hospital, Fudan University, Shanghai, 200032, China.
Background: Genomic studies have linked single nucleotide variants in the enhancer region of the leukemia inhibitory factor receptor (Lifr) gene to chromatin accessibility and the regulation of self-renewal in mouse embryonic stem cells (mESCs). However, the underlying mechanisms remain unclear. This study investigates the role of the transcription factor BTB and CNC homology 1 (BACH1) in regulating the Lifr enhancer and its impact on mESC pluripotency.
View Article and Find Full Text PDFThe role of ASS1 in mouse embryonic stem cell differentiation into mesendoderm lineages.
Stem Cell Res Ther
September 2025
Research Center for Animal Genetic Resources of Mongolia Plateau, College of Life Sciences, Inner Mongolia University, Hohhot, 010020, China.
Background: Argininosuccinate synthase (ASS1) is a pivotal enzyme involved in the urea cycle, playing a crucial role in aspartate catabolism, arginine and nitric oxide biosynthesis. These biological processes are crucial for the growth and development of mammals. However, the functions of urea cycle-related genes in mouse embryonic stem cells (mESCs) remain largely unclear.
View Article and Find Full Text PDFLoss of CD90 alters EMT-associated features and drug sensitivity in U-CH1 chordoma cells.
Naunyn Schmiedebergs Arch Pharmacol
September 2025
Department of Medical Genetics, School of Medicine, Yeditepe University, Istanbul, 34755, Turkey.
Chordoma is a rare, slow-growing malignancy of notochordal origin characterized by a high degree of chemoresistance and limited therapeutic responsiveness. Despite advances in molecular profiling, the mechanisms underlying its cellular plasticity and therapy evasion remain incompletely defined. Emerging evidence across solid tumors suggests that cancer stem-like cells (CSCs) and the epithelial-to-mesenchymal transition (EMT) play central roles in driving tumor progression, metastatic potential, and drug resistance.
View Article and Find Full Text PDFPorous microscaffold enables spontaneous hematopoietic cell differentiation and continuous macrophage production from hPSCs for therapy.
Biomaterials
August 2025
Center for Regeneration, Aging and Chronic Diseases, School of Basic Medical Sciences, Tsinghua University, Beijing, 100084, China; SXMU-Tsinghua Collaborative Center for Frontier Medicine, Taiyuan, Shanxi Province, 030001, China; State Key Laboratory for Complex, Severe and Rare Diseases, Tsinghua
Macrophages play critical roles in various physiological and pathological processes, yet their scalable production for therapeutic applications remains a challenge. Here, we present a porous microscaffold (PMS) that enables robust hematopoietic differentiation from human pluripotent stem cell (hPSC)-derived mesoderm. Within PMS, mesoderm cells self-organize into vascular structures reminiscent of the early aorta-gonad-mesonephros (AGM) niches, promoting efficient endothelial-to-hematopoietic transition with minimal cytokine supplementation.
View Article and Find Full Text PDF